Dialog Box

Loading...
27 March 2017

Cancer drug added to PBS list

Rare cancer drug added to PBS

Brentuximab vedotin, sold as Adcetris, was one of several medicines added to the PBS by the federal government on Saturday 25 March. 

It is used to treat a rare subtype of Hodgkin lymphoma often affecting young people.

Prior to listing, it could cost patients tens of thousands of dollars for treatment at about $16,000 a cycle, Lymphoma Australia CEO Sharon Winton said.

"The problem in the past for this subtype of Hodgkin lymphoma, is there hasn't been very much available," she said.

"Generally young patients don't have any treatment options left to give them a chance for a cure.

"For this drug to now be available without them considering selling their houses or taking out superannuation ... it will save financial stress."

Ms Winton said the drug could be used by some 100 cancer sufferers per year and either extend their life, act as a cure or allow them time to access other treatments.

"It now means they can actually have a chance of surviving," Ms Winton said.

 

Source: SBS News.

For the full article: http://www.sbs.com.au/news/article/2017/03/25/rare-cancer-drug-added-pbs

 

Channel 9 coverage: http://www.9news.com.au/national/2017/03/25/17/18/thousands-of-australians-to-beneft-from-latest-changes-to-pbs

 

Category: General News
Tags: cancer drug new PBS pharmaceutical treatment hodgkin rare cancer,